Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,382 | 85 | 81.1% |
| Food and Beverage | $20,459 | 1,006 | 12.4% |
| Travel and Lodging | $8,013 | 51 | 4.8% |
| Consulting Fee | $2,550 | 1 | 1.5% |
| Education | $175.44 | 9 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $103,800 | 257 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $27,180 | 60 | $0 (2021) |
| ABBVIE INC. | $8,359 | 34 | $0 (2023) |
| Tandem Diabetes Care, Inc. | $7,733 | 31 | $0 (2022) |
| Mannkind Corporation | $5,115 | 51 | $0 (2024) |
| Lilly USA, LLC | $3,159 | 100 | $0 (2024) |
| Amgen Inc. | $1,122 | 74 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,033 | 76 | $0 (2024) |
| Abbott Laboratories | $682.84 | 42 | $0 (2024) |
| Insulet Corporation | $648.71 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,221 | 120 | Novo Nordisk Inc ($337.62) |
| 2023 | $2,128 | 127 | Novo Nordisk Inc ($357.24) |
| 2022 | $11,357 | 168 | Novo Nordisk Inc ($9,257) |
| 2021 | $28,084 | 80 | Novo Nordisk Inc ($27,227) |
| 2020 | $12,733 | 66 | Tandem Diabetes Care, Inc. ($6,716) |
| 2019 | $25,249 | 186 | Novo Nordisk Inc ($12,835) |
| 2018 | $48,503 | 222 | Novo Nordisk Inc ($21,754) |
| 2017 | $35,362 | 184 | Novo Nordisk Inc ($26,383) |
All Payment Transactions
1,153 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | CRENESSITY (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $0.60 | General |
| Category: Insulin Pump | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $40.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Insulin Pump | ||||||
| 11/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $0.41 | General |
| Category: Insulin Pump | ||||||
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Rare Disease | ||||||
| 11/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Insulin Pump | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/30/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,943 | 12,096 | $761,179 | $229,423 |
| 2022 | 32 | 3,971 | 11,475 | $699,973 | $209,655 |
| 2021 | 32 | 4,006 | 11,680 | $691,295 | $212,697 |
| 2020 | 32 | 3,900 | 12,290 | $685,891 | $207,125 |
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 49 | 5,100 | $134,035 | $91,976 | 68.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 339 | 511 | $72,163 | $29,040 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 245 | $55,607 | $21,290 | 38.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 334 | 618 | $53,274 | $10,084 | 18.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 315 | 625 | $53,876 | $8,155 | 15.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 380 | 730 | $40,061 | $7,503 | 18.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 252 | 437 | $37,679 | $7,164 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 420 | 821 | $23,170 | $6,848 | 29.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 340 | 636 | $44,849 | $5,587 | 12.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 255 | 523 | $36,881 | $4,960 | 13.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 118 | 171 | $30,431 | $4,874 | 16.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 57 | 60 | $24,604 | $4,504 | 18.3% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 94 | 175 | $23,314 | $4,375 | 18.8% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 94 | 174 | $12,767 | $3,664 | 28.7% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 71 | 135 | $17,697 | $3,612 | 20.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 190 | 343 | $16,129 | $2,156 | 13.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 33 | 53 | $10,706 | $2,144 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,542 | $2,119 | 28.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 61 | 61 | $25,897 | $2,092 | 8.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 42 | 79 | $8,047 | $1,424 | 17.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 56 | 92 | $10,980 | $1,345 | 12.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 49 | 72 | $2,165 | $943.50 | 43.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 90 | $5,007 | $932.40 | 18.6% |
| 83550 | Iron binding capacity | Office | 2023 | 41 | 63 | $1,862 | $522.77 | 28.1% |
| 83540 | Iron level | Office | 2023 | 48 | 80 | $1,748 | $494.52 | 28.3% |
About Dr. Casey Page, MD
Dr. Casey Page, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215933577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Casey Page, MD has received a total of $165,638 in payments from pharmaceutical and medical device companies, with $2,221 received in 2024. These payments were reported across 1,153 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($134,382).
As a Medicare-enrolled provider, Page has provided services to 15,820 Medicare beneficiaries, totaling 47,541 services with total Medicare billing of $858,901. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Knoxville, TN
- Active Since 06/22/2005
- Last Updated 06/18/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1215933577
Products in Payments
- STEGLATRO (Drug) $26,932
- RYBELSUS (Drug) $26,406
- Ozempic (Drug) $18,298
- Tresiba (Drug) $16,613
- Victoza (Drug) $12,345
- Rybelsus (Drug) $9,158
- Androgel (Drug) $6,867
- t:slim X2 insulin pump (Device) $6,716
- AFREZZA (Drug) $5,115
- Xultophy 100/3.6 (Drug) $3,282
- TRADJENTA (Drug) $1,750
- Synthroid (Drug) $1,411
- t-slim insulin pump (Device) $1,000
- Omnipod (Device) $648.71
- Korlym (Drug) $634.84
- JARDIANCE (Drug) $487.05
- Dexcom G6 Transmitter (Medical Supply) $421.75
- Kerendia (Drug) $412.90
- Repatha (Biological) $389.69
- TRULICITY (Drug) $387.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Knoxville
Amit Vora, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $728,648
Dr. David Irizarry, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $89,566
Mubashir Mahmood, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $50,171
Thomas Doty, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23,541
Daniel Mccammon, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,890
Gregory Moffitt, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,924